Treating cancer is complicated – it requires a patient-centered approach in an environment of rapidly evolving treatment options. As a result, creating quality measures that assess cancer care in a meaningful and effective way can be a challenging prospect. Gaps in quality measures used in new payment models, such as the Oncology Care Model, may cause missed signals that can impact the way providers deliver and improve care.
To better understand these gaps and to identify potential avenues to improve oncology measurement, NPC partnered with Discern Health to host a webinar on Wednesday, April 26, 2017, from 1-2:30 p.m. to discuss its peer-reviewed research and white paper. The panel was moderated by NPC Vice President of Health Services Research Kimberly Westrich, and featured:
- Tom Valuck, MD, JD, Partner, Discern Health;
- Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy;
- Robert S. Miller, MD, FACP, FASCO; Vice President and Medical Director, CancerLinQ; American Society of Clinical Oncology; and
- Alan Balch, PhD, Chief Executive Officer, National Patient Advocate Foundation.